A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.
about
LITTLE FISH, BIG DATA: ZEBRAFISH AS A MODEL FOR CARDIOVASCULAR AND METABOLIC DISEASE.The evolving role of ankyrin-B in cardiovascular disease.Pediatric Cardiomyopathies.Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.A Langendorff-like system to quantify cardiac pump function in adult zebrafish
P2860
A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.
@en
A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.
@nl
type
label
A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.
@en
A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.
@nl
prefLabel
A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.
@en
A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.
@nl
P2093
P2860
P1433
P1476
A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.
@en
P2093
J Martijn Bos
Jianan Wang
Jianhua Chen
Liqun Zhao
Margaret M Redfield
Michael J Ackerman
Pamela A Long
Rhianna S Sundsbak
Stephen C Ekker
Timothy M Olson
P2860
P356
10.1172/JCI.INSIGHT.88797
P577
2016-09-01T00:00:00Z